7.52

1.62% 0.12

Pre-market: 7.21 -0.31 -4.12%

Hcw Biologics Inc (HCWB)

Overview News Price History Financials Discussions Forecast

Hcw Biologics Inc stock is traded at $7.52, with a volume of 12,932. It is up +1.62% in the last 24 hours and down -37.33% over the past month. HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

Previous Close:

$7.40

Open:

$7.3

24h Volume:

12,932

Relative Volume:

0.09

Market Cap:

$8.94M

Revenue:

$3.50M

Net Income/Loss:

$-37.33M

P/E Ratio:

-7.52

EPS:

-1

Net Cash Flow:

$-19.15M

1W Performance:

-5.53%

1M Performance:

-37.33%

6M Performance:

-57.37%

1Y Performance:

-86.67%

1-Day Range:

$7.30

$7.64

1-Week Range:

$6.65

$8.42

52-Week Range:

$6.65

$100.80

Hcw Biologics Inc Stock (HCWB) Company Profile

Name

Hcw Biologics Inc

Sector

Healthcare (1153)

Industry

Biotechnology (664)

Phone

954-842-2024

Address

2929 N COMMERCE PKWY, MIRAMAR

Employee

Twitter

Next Earnings Date

2025-04-01

Latest SEC Filings

HCWB's Discussions on Twitter

Compare HCWB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HCWB Hcw Biologics Inc	7.52	8.94M	3.50M	-37.33M	-19.15M	-1.00
VRTX Vertex Pharmaceuticals Inc	503.50	126.09B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	568.91	64.01B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	629.51	36.63B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	257.19	30.64B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	249.77	27.24B	3.81B	-644.79M	-669.77M	-6.24

Hcw Biologics Inc Stock (HCWB) Latest News

Apr 26, 2025

HCWB stock touches 52-week low at $6.99 amid sharp annual decline - Investing.com Australia

Apr 26, 2025

Apr 25, 2025

HCW Biologics (NASDAQ:HCWB) Trading 0.1% Higher – Here’s Why - Defense World

Apr 25, 2025

Apr 23, 2025

HCW Biologics faces lawsuit over construction contract breach - Investing.com Australia

Apr 23, 2025

Apr 22, 2025

HCW Biologics faces lawsuit over construction contract breach By Investing.com - Investing.com Canada

Apr 22, 2025

Apr 14, 2025

HCW Biologics enters key agreements; SEC non-review of filing By Investing.com - Investing.com South Africa

Apr 14, 2025

HCW Biologics enters key agreements; SEC non-review of filing - Investing.com

Apr 14, 2025

HCWB stock touches 52-week low at $8.04 amid market challenges By Investing.com - Investing.com South Africa

Apr 14, 2025

HCWB stock touches 52-week low at $8.04 amid market challenges - Investing.com Canada

Apr 14, 2025

Apr 07, 2025

HCWB stock touches 52-week low at $0.2 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 07, 2025

HCWB stock touches 52-week low at $0.2 amid sharp annual decline - Investing.com Australia

Apr 07, 2025

Apr 03, 2025

HCW Biologics Stock Set to Reverse Split on Friday, April 11th (NASDAQ:HCWB) - Defense World

Apr 03, 2025

Apr 02, 2025

HCW Biologics to Implement 1-for-40 Reverse Stock Split - MarketScreener

Apr 02, 2025

Apr 01, 2025

HCW Biologics approves reverse stock split to meet Nasdaq rules By Investing.com - Investing.com South Africa

Apr 01, 2025

HCW Biologics approves reverse stock split By Investing.com - Investing.com Canada

Apr 01, 2025

Major Stock Restructuring: HCW Biologics Announces 40:1 Reverse Split for Nasdaq Compliance - Stock Titan

Apr 01, 2025

Warner Bros Discovery Stock (NASDAQ:WBD) Slides as Film Boss Replacements Considered - The Globe and Mail

Apr 01, 2025

How major US stock indexes fared Tuesday, 4/1/2025 - The Globe and Mail

Apr 01, 2025

Mar 30, 2025

HCW BIOLOGICS Earnings Preview: Recent $HCWB Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 30, 2025

Mar 29, 2025

HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results - The Manila Times

Mar 29, 2025

Mar 28, 2025

HCW Biologics Inc. SEC 10-K Report - TradingView

Mar 28, 2025

HCW Biologics Secures FDA Green Light for Alopecia Treatment Despite $30M Annual Loss - Stock Titan

Mar 28, 2025

Mar 19, 2025

HCW Biologics amends agreement with WY Biotech amid delays - Investing.com

Mar 19, 2025

Mar 11, 2025

Stocks Attempt to Stabilize as Trump Set to Meet with Top US Executives - The Globe and Mail

Mar 11, 2025

Mar 07, 2025

HCW Biologics Granted Extension by the Nasdaq Hearings - GlobeNewswire

Mar 07, 2025

Mar 06, 2025

HCW Biologics Inc. Receives Extension from Nasdaq to Regain Compliance with Listing Rules - Nasdaq

Mar 06, 2025

Can HCW Biologics Meet Nasdaq's New June Deadline? Key Details Revealed - StockTitan

Mar 06, 2025

Feb 24, 2025

HCW Biologics Inc. announced that it expects to receive $20 million in funding -February 19, 2025 - Marketscreener.com

Feb 24, 2025

Zeta (ZETA) Q4 Earnings: What To Expect - The Globe and Mail

Feb 24, 2025

Feb 10, 2025